Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Mechanism and application of injectable hydrogel as carrier system in the treatment of osteoarthritis

Zhang BG., Liu Q., Ma T., Liu JJ., Zhang Y., Liu F.

Narrative Review on Osteoarthritis, Cartilage Damage, published in Front Bioeng Biotechnol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Front Bioeng Biotechnol (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41104102
PMCID
PMC12521118
DOI
10.3389/fbioe.2025.1636518

Abstract (original English)

Osteoarthritis (OA) is a disabling degenerative disease that affects synovial joints and leads to cartilage degeneration, which can cause progressive joint damage, chronic pain and functional loss. Because its specific pathogenesis is still unclear, conventional treatment methods are still difficult to achieve satisfactory therapeutic effects. Therefore, finding alternative new methods for treating OA remains a formidable challenge. Hydrogel is a kind of polymer material with good biocompatibility and biodegradability, and it is a new method for the treatment of osteoarthritis. Injectable hydrogel drug delivery platforms have shown many advantages in the treatment of OA, including improved biocompatibility, biodegradability, and low immunogenicity. Injectable hydrogels, as delivery systems, can deliver drugs to the joint cavity in a controlled manner and continuously release them, enhancing drug loading capacity and increasing sensitivity to improve therapeutic effects. This article summarizes the types of injectable hydrogels, analyzes their application as delivery systems in OA, and discusses the mechanisms of injectable hydrogels in the treatment of OA, such as anti-inflammation, anti-oxidative stress, and promotion of articular cartilage regeneration. Meanwhile, the deficiencies of injectable hydrogel drug delivery platforms in the OA field were summarized, and the future r

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research